Abstract
Nowadays, in silico tools are widely used to provide the potential structure of the metabolites formed depending on the site of metabolism. These methods can also highlight the molecular moieties that help to direct the molecule into the cytochrome cavity so that the site of metabolism is in proximity to the catalytic center. In this minireview, we summarized three aspects of the in silico methods in the application of prediction of ADME (absorption, distribution, metabolism and excretion) properties of compounds: structure-based approaches for predicting molecular modeling of drug metabolizing enzymes; in silico metabolite prediction; and pharmacophore models for analysis substrate specificity. Moreover, we also extended the in silico studies in Chinese herbal medicines (CHM) research.
Keywords: In silico, ADME, prediction, CHM
Graphical Abstract
Current Drug Metabolism
Title:In-silico ADME Studies for New Drug Discovery: From Chemical Compounds to Chinese Herbal Medicines
Volume: 18 Issue: 6
Author(s): Guojun Yan, Xiaobing Wang, Zhou Chen, Xianhui Wu, Jinhuo Pan, Yushen Huang, Gang Wan and Zhaogang Yang*
Affiliation:
- Ohio State University, 151 W Woodruff Ave, Columbus, OH 43210,United States
Keywords: In silico, ADME, prediction, CHM
Abstract: Nowadays, in silico tools are widely used to provide the potential structure of the metabolites formed depending on the site of metabolism. These methods can also highlight the molecular moieties that help to direct the molecule into the cytochrome cavity so that the site of metabolism is in proximity to the catalytic center. In this minireview, we summarized three aspects of the in silico methods in the application of prediction of ADME (absorption, distribution, metabolism and excretion) properties of compounds: structure-based approaches for predicting molecular modeling of drug metabolizing enzymes; in silico metabolite prediction; and pharmacophore models for analysis substrate specificity. Moreover, we also extended the in silico studies in Chinese herbal medicines (CHM) research.
Export Options
About this article
Cite this article as:
Yan Guojun , Wang Xiaobing , Chen Zhou , Wu Xianhui , Pan Jinhuo , Huang Yushen, Wan Gang and Yang Zhaogang*, In-silico ADME Studies for New Drug Discovery: From Chemical Compounds to Chinese Herbal Medicines, Current Drug Metabolism 2017; 18 (6) . https://dx.doi.org/10.2174/1389200218666170316094104
DOI https://dx.doi.org/10.2174/1389200218666170316094104 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subtype-Selective Dopamine Receptor Radioligands for PET Imaging: Current Status and Recent Developments
Current Medicinal Chemistry γ δ T Cell Modulation in Anticancer Treatment
Current Cancer Drug Targets The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Plant Polyphenolics as Anti-Invasive Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression
Current Enzyme Inhibition Epigenetic Therapies of Cancer
Current Cancer Therapy Reviews Long Non-Coding RNAs As Epigenetic Regulators in Cancer
Current Pharmaceutical Design MiRNA-based Therapeutic Strategy in Lung Cancer
Current Pharmaceutical Design Novel Glitazones with Diverse Peroxisome Proliferator Activated Receptor Modulatory Potential
Current Bioactive Compounds Protein Bioinformatics Applied to Virology
Current Protein & Peptide Science Drug Eluting Stents and Beyond
Current Pharmaceutical Design RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry Axitinib in the Treatment of Head and Neck Malignancies
Current Clinical Pharmacology Cholesterol, Lipids, Amyloid Beta, and Alzheimers
Current Alzheimer Research Chemotypic Variation of Lupeol in Roots of Hemidesmus indicus (L.) R.Br. from Different Agroclimatic Regions of Madhya Pradesh State of India
Current Traditional Medicine Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases
Current Medicinal Chemistry PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging
Current Protein & Peptide Science Regulation of Mitochondrial Function and its Impact in Metabolic Stress
Current Medicinal Chemistry Angiogenesis and Angiogenic Inhibitors in Non Small Cell Lung Cancer
Current Angiogenesis (Discontinued) Pharmacogenetics and Pharmagenomics, Trends in Normal and Pathological Aging Studies: Focus on p53
Current Pharmaceutical Design